After third generation EGFR-TKI resistance, where is the path of advanced NSCLC patients with EGFR mutations

After third generation EGFR-TKI resistance, where is the path of advanced NSCLC patients with EGFR mutations

PENG Ling, DONG Xiaorong

PDF(894 KB)

Tumor website：www.tumorsci.org E-mail Alert

PDF(894 KB)

Tumor ›› 2024, Vol. 44 ›› Issue (06) : 566-573. DOI: 10.3781/j.issn.1000-7431.2024.2404-0180

After third generation EGFR-TKI resistance, where is the path of advanced NSCLC patients with EGFR mutations

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 44(06): 566-573 https://doi.org/10.3781/j.issn.1000-7431.2024.2404-0180

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(894 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉